Shukra Pharmaceuticals Ltd

Know More
NSEBSE
Stock not tradded

304.2514.45 (4.99%)

04:01 PM,1st Mar 2024

BSE : 524632

NSE :

Sector : Health care

ISIN Code : INE551C01028

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Mar 01 2024 | 04:01 PM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September 2016. The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin) Anti Biotics (Cephalosporin) Anti Biotics Macrolides Quinolones Anti Bacterial Anti Fungal Anti Malarial Anti Viral Anti Protozoal Anti Anthelmintic Sedative and Tranquilliser Anti Depressant Anti Manic Anti Emetic Anti Ulcer Beta Blockers Diuretics Analgesic Analgesic (NASID) Muscle Relaxants Anti Tuberculosis Vitamin Products Anti Allergics Corticosteroids Hyper and Hypoglycemic Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum) Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus) Intas Pharmaceuticals Limited Cadila Pharmaceuticals Limited Makers Laboratories Limited Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 2013-14 the Company got approval from Hon'ble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited (Transferor Company) with Relish Pharmaceuticals Limited (Transferee Company) and Re-organization of Share Capital of Relish Pharmaceuticals Limited (Transferee Company) through Scheme of Arrangement vide Hon'ble High Court of Gujarat order dated 20 Dec' 2013.

Shukra Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

333

EPS - TTM (₹) [S]

16.93

P/E Ratio (X) [S]

7.53

Face Value (₹) 10
Latest Dividend (%)5.00
Latest Dividend Date 15 Sep 2023
Dividend Yield (%) 0.06
Book Value Share (₹) [S]40.43
P/B Ratio (₹) [S]7.53
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

304.25

304.25

Week Low/High

238.50

304.25

Month Low/High

142.90

304.25

Year Low/High

41.76

304.00

All time Low/High

0.09

304.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week27.57%%0.820.57%
1 Month98.79%%2.932.96%
3 Month217.26%%9.2810.22%
6 Month114.26%%12.7814.94%
1 Year471.04%%24.1328.01%
3 Year3381.12%%47.9351.33%

Company Info

Company Information

Chairman & Managing Director : Dakshesh Shah

Executive Director : Payal Mehta

Independent Director : Bhoomiben Patel

Independent Director : Sarjeevan Singh

Independent Director : Sonal Deepalbhai Gandhi

Executive Director : Sanskruti Patel

Executive Director : Dhruvin Shah

Independent Director : Pinki Nirmal Sagar

Registered Office: 3 rd Floor Dev House, Opp WIAA Office Judges Bungalo,Ahmedabad,Gujarat-380054 Ph: 91-079-66522247/27498515

Email:info@relishpharma.com

URL:http://www.shukrapharmeceuticals.com